Información bibliográfica
GuíaWHO consolidated guidelines for the management of common childhood illness: management of sickle-cell disease in children and adolescents
Año de publicación2026
Institución emisoraWorld Health Organization
Recomendación
Nueva
In children and adolescents (aged 9 months to 19 years) with sickle-cell anaemia (SCA), hydroxyurea therapy is recommended regardless of clinical severity.
Recomendado a favor
Fuerte
Certeza de la evidencia
Baja